Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
- DOI
- 10.1371/journal.pmed.1002136
- Published
- 2016 Dec
- Container
- PLoS medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pmed.1002136,
title = {Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.},
author = {Goh G and Schmid R and Guiver K and Arpornwirat W and Chitapanarux I and Ganju V and Im SA and Kim SB and Dechaphunkul A and Maneechavakajorn J and Spector N and Yau T and Afrit M and Ahmed SB and Johnston SR and Gibson N and Uttenreuther-Fischer M and Herrero J and Swanton C},
year = {2016},
journal = {PLoS medicine},
doi = {10.1371/journal.pmed.1002136},
url = {https://doi.org/10.1371/journal.pmed.1002136}
}RIS
TY - JOUR TI - Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine. AU - Goh G AU - Schmid R AU - Guiver K AU - Arpornwirat W AU - Chitapanarux I AU - Ganju V AU - Im SA AU - Kim SB AU - Dechaphunkul A AU - Maneechavakajorn J AU - Spector N AU - Yau T AU - Afrit M AU - Ahmed SB AU - Johnston SR AU - Gibson N AU - Uttenreuther-Fischer M AU - Herrero J AU - Swanton C PY - 2016 JO - PLoS medicine DO - 10.1371/journal.pmed.1002136 UR - https://doi.org/10.1371/journal.pmed.1002136 ER -
APA
G, G., R, S., K, G., W, A., I, C., V, G., SA, I., SB, K., A, D., J, M., N, S., T, Y., M, A., SB, A., SR, J., N, G., M, U., J, H., & C, S. (2016). Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.. PLoS medicine. https://doi.org/10.1371/journal.pmed.1002136
Source records
- pubmed · retrieved 2026-09-26T23:23:17.227Z
- europe-pmc · retrieved 2026-09-26T23:23:17.235Z
- doaj · retrieved 2026-09-26T23:23:17.235Z